Home Markets Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

May 28, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/aurobindo-pharma-outperforms-expectations-with-strong-q4-eyes-robust-growth-ahead-3457980

You May Also Like

Qantas to close low-cost arm Jetstar Asia and cycle $326.4 million of capital

China’s saucemaker Foshan Haitian to raise $1.2 bln in Hong Kong IPO

India’s Maruti Suzuki cuts near-term EV production amid rare earths crisis

Mexico stocks higher at close of trade; S&P/BMV IPC up 0.49%

Starbucks accelerates new staffing model to all North American stores

US senators grill Trump CFTC nominee over industry ties, commission vacancies